Orchard Therapeutics plc
USD16.70
+0.05 (+0.30%)
CEO
Hubert Baburaj Gaspar
IPO Date
2018-10-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$16.65
Prev. Close
$16.65
Day Low
$16.64
Day High
$16.72
52W Low
$4.24
52W High
$16.72
Market Cap
$0.38B
Volume
0.37M
| -4.5 |
| 31 Dec 2020 | FY | 67.0% | -5856.6% | -85.2% | -54.1% | 0.33 | 4.34 | -2.8 |
| 31 Dec 2019 | FY | 68.0% | -6503.1% | -54.6% | -40.9% | 0.15 | 6.26 | -7.8 |
| 31 Dec 2018 | FY | 79.7% | -11102.8% | -74.0% | -63.0% | 0.00 | 7.42 | -1.5 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -46.0% | -40.8% | 0.00 | 8.76 | -3.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 115.5% | -445.6% | 0.00 | 1.04 | -7.4 |
| -2.0 |
| 31 Mar 2023 | Q1 | 70.3% | -1407.6% | -17.1% | -8.0% | 0.52 | 3.12 | -1.1 |
| 31 Dec 2022 | Q4 | 127.3% | 1930.9% | 137.3% | 61.6% | 0.59 | 2.78 | 0.1 |
| 30 Sept 2022 | Q3 | 71.5% | -823.4% | -38.5% | -20.3% | 0.47 | 3.57 | -0.3 |
| 30 Jun 2022 | Q2 | 74.3% | -1165.7% | -34.8% | -19.6% | 0.41 | 4.24 | -0.4 |
| 31 Mar 2022 | Q1 | 71.6% | -801.9% | -25.2% | -15.2% | 0.35 | 5.06 | -0.5 |
| 31 Dec 2021 | Q4 | 100.0% | -7525.5% | -17.3% | -11.3% | 0.28 | 6.43 | -1.2 |
| 30 Sept 2021 | Q3 | 81.0% | -3057.5% | -15.1% | -10.2% | 0.25 | 6.59 | -2.0 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -13.8% | -10.0% | 0.23 | 7.43 | -3.8 |